調æ»å ±éèšè ãCOVIDãã©ãã£ã圢æã®å®æ ãèšé²ïŒãæ€é²ã¯æåããå§ãŸãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
調æ»å ±éèšè ã®ãœãã¢ã»ã€ã©ã€ãžã£ã¯æ°åã§ãçµ±äžãããCOVID-19ã®ç©èªãåæã«ã©ã®ããã«åœ¢æããããäºå®ããšåŒã°ããããã®ã圢äœã£ãããæãåºããŸããã5幎ã«ãããåæã«åºã¥ãã圌女ã¯ãžã§ã³ã»ãã£ã³ãã«å士ã«ãåæã®ã¡ãŒã«ãææžã代æ¿çãªèŠè§£ãå°ããããšã®éèŠæ§ã匷調ããŠãããšèªããŸããã圌女ã¯ãããããã¹ãŠãžã®è§£æ¯å€ã¯ãç¥èãšçå®ã§ãããšè¿°ã¹ãŸããã
調æ»å ±éèšè ã®ãœãã¢ã»ã€ã©ã€ãžã£ã¯æ°èã3/11 ãã€ã©ã«ã»ãã€ã¯ãªãŒããŒïŒ2020幎3æ11æ¥ã«ãã³ãããã¯ã宣èšãããç§ãã¡ã®äžçã¯æ°žé ã«å€ãã£ããã®äžã§ãCOVID-19ã«é¢ããæ å ±ãåœåããã©ã®ããã«åœ¢äœãããããæ¢ã£ãŠããããæ€é²ã¯æåããå§ãŸã£ãŠãããã®ã ãšããã
4æ19æ¥ã®ã€ã³ã¿ãã¥ãŒã§ãã€ã©ã€ãžã£ã¯ãžã§ã³ã»ãã£ã³ãã«ïŒPh.D.ïŒã«å¯Ÿããåæžã¯ææžãã¡ãŒã«ãç§åŠè«æãå éšåçºè ã®èšŒèšãªã©ã5幎ã«ãããåæã«åºã¥ããŠãããšèªã£ãã
æžåã¯äžçä¿å¥æ©é¢ïŒWHOïŒãCOVID-19ãäžççãªãã³ãããã¯ãšå®£èšããæ¥ãæããŠãããã€ã©ã€ãžã£ã¯ããã®ç¬éã«ãåçš®æ©é¢ãã¡ãã£ã¢ããã¯ãããžãŒãã©ãããã©ãŒã ã«ãŸãããçµ±äžçãªç©èªãå éããå ¬åŒåãããäœãèšããŠäœãèšããªããã圢äœããããšè¿°ã¹ãã
圌女ã¯ããã®å®£èšä»¥åã屿©ã®ããåæã®æ®µéãããäž»èŠãªç«å Žããã§ã«åºãŸãã€ã€ãã£ããšæ¯ãè¿ãã
2020幎2æã«ãã©ã³ã»ãããã«æ²èŒããã声æã¯ããCOVID-19ã«èªç¶èµ·æºããªããšç€ºåããé°è¬è«ã匷ãéé£ããããã«ç§ãã¡ã¯çµæããããšå®£èšããŠããã
ã€ã©ã€ãžã£ã¯ããã®å£°æã¯èè ãã®å©ççžåãåæ ããŠãããšè¿°ã¹ããããã®ã©ã³ã»ããã®å ±å声æãèŠãã°âŠâŠé¢äžãã27人ã®ç§åŠè ã®ãã¡26人ããæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æâŠâŠãããã¯ãã®è³éæäŸè ãšã€ãªããããã£ããšæããŸãããšåœŒå¥³ã¯èšãããããã£ãŠããšãŠã瀺åçã§ã¯ãããŸãããïŒã
ã€ã©ã€ãžã£ã«ããã°ããã®å£°æã¯ç°è«ãéãã空æ°ã¥ããã«ãäžåœ¹è²·ã£ãã
ããŠã€ã«ã¹ã®èªç¶èµ·æºãå®å šã«åãæšãŠãåãç· ãŸããè¡ãããã®ã§ãããšåœŒå¥³ã¯è¿°ã¹ããããã«çåãåããè ã¯ãé°è¬è«è ããšã¬ããã«ã貌ããããšããã
ããã®æãã®ã¯ã¯ãã³ãåŸ ããªããã°ãªããªãã
ãšã©ã€ãžã£ã¯èæžå šäœãéããŠã諞æ©é¢ãå調ããŠâå ¬èªã®ç©èªâã匷åããä»£æ¿æ¡ãèã«è¿œããã£ãçµç·¯ãèšé²ããŠããã圌女ã¯ãåææ²»çãã¯ã¯ãã³ã®å®å šæ§ã·ã°ãã«ã«é¢ããç ç©¶ãå«ããæ€åã»åãäžããããç ç©¶ã®äºäŸãæããã
è¥å¹Žç·æ§ã®å¿ççãªã¹ã¯ãæ€èšŒããããæ»èªæžã¿ç ç©¶ã¯ãç±³é£åå»è¬åå±ïŒFDAïŒã5ã11æ³ãžã®ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³æ¿èªã審è°ããæç¥šã®æ°æ¥åã«ã匷å¶çã«æ€åãããããšããšã©ã€ãžã£ã¯è¿°ã¹ãã
ãããã¯ãçãå»¶ã³ãŠããã°æµããå€ããããæ¥µããŠéèŠãªç ç©¶ã§ããããšåœŒå¥³ã¯èªã£ãã
圌女ã¯ãŸããæ©é¢æšªæã®åœ¹å²ã®éè€ã«ãæžå¿µã瀺ããã
ããã¥ãŒã€ã³ã°ã©ã³ãã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã·ã³ã®ç·šéè ã§ãããFDAã®å§å¡ãåãããšãªãã¯ã»ã«ãŒãã³å»åž«ããã¯ã¯ãã³ã®å®å šæ§ã¯å®éã«å±éããŠã¿ããŸã§åãããªããšèšã£ãŠããŸããããšãšã©ã€ãžã£ã¯è¿°ã¹ãããèŠããã«ãäžè¬ã®äººã ãã¢ã«ã¢ãããšããŠäœ¿ãããã®ã§ããã
圌女ã®åæã¯ãCOVID-19åææ²»çã®æ±ãã«ãçŠç¹ãåœãŠãã
ãšã©ã€ãžã£ã¯ãããããã·ã¯ãããã³ãã€ãã«ã¡ã¯ãã³ãšãã£ãè¬å€ãè²¶ããããã®ã倿¹é¢ããã®ãåãçµã¿ããã£ããšè¿°ã¹ãFDAã®ãããªãã¯éЬã§ã¯ãªãããšãããã€ãŒãããã®äžäŸã«æããã
ãããã®åãã¯ãè¬å€ã®äœ¿çšãå¶éããèŠå¶å€æãšäžŠè¡ããŠèµ·ããã圌女ã¯ããããã倿ãã¯ã¯ãã³ã®ç·æ¥äœ¿çšèš±å¯ïŒEUAïŒã®èŠä»¶ãšçµã³ä»ããã
ãæ¡ä»¶ã®äžã€ã¯ãCOVID-19ã«å¯ŸããŠæ¢åã®æ²»çããªãããšã§ããããšåœŒå¥³ã¯èšãããå®äŸ¡ãªãžã§ããªãã¯è¬ãCOVID-19ã®æå¹ãªæ²»çã«ãªã£ãŠããŸã£ãŠã¯å°ããç§ãã¡ã¯ãã®âæãã®ã¯ã¯ãã³âãç»å Žããã®ãåŸ ããªããã°ãªããªãã®ã§ããã
èŠå¶åœå±ã¯ãåœæ°ãå®ãããã®ç²Ÿæ»ãå°œãããªãã£ãã
ãšã©ã€ãžã£ã¯ãŸãããã¡ã€ã¶ãŒã®å®å šæ§ããŒã¿ã®æ±ãæ¹ã«ãçåãåãããã¯ã¯ãã³å±éåããè³åäžããããããå¿ççãªã©ã®æœåšçãªæå®³äºè±¡ãå éšå ±åãè«®åäŒè°ã§åæãããŠããããšãææããã
ã圌ãã®ã¬ãŒããŒã«ã¯å ¥ã£ãŠãããæ°ã«æåããææ¡ããŠããã®ã§ãããšãšã©ã€ãžã£ã¯èšã£ãã
圌女ã¯ãåŠåš ã»æä¹³ã«é¢ããã¬ãã¥ãŒãªã©ãä»ã®ç€Ÿå ææžã«ãèšåãåŠå©Šãä¹³å ãžã®ããããšãããã害ãã詳现ã«èšããå ¬è¡è¡çåœå±ãåŠå©Šãžã®æ¥çš®æšå¥šãæ¡å€§ããçŽåã«æçµåãããŠãããšè¿°ã¹ãã
ã¯ã¯ãã³ã¯ãå®å šããã¯çšé ããã¯ããã«å±éºãªãã®ã ã£ãããšãšã©ã€ãžã£ã¯èªã£ãã
ãšã©ã€ãžã£ã¯ãèŠå¶åœå±ãç€Ÿå ææžã§ã¯ãªãå ¬çã«å ¥æå¯èœãªããŒã¿ã«äŸæ ããŠããããšã¯èªãã€ã€ããéèŠãªæ å ±ãé瀺ãããŠããªãã£ããšäž»åŒµããã
ã圌ãã¯çžå¿ã®å°œè·èª¿æ»ãããªãã£ãã®ã§ãããšãšã©ã€ãžã£ã¯èšã£ããããã®çµæãè£œè¬æ¥çãå€ãã®çœªãèŠéãããããšã«ãªããŸãããã
ãèªããã®ã¯â圌ãã®å ¬èªç©èªâã ãã
ç§åŠçã»èŠå¶ç倿ãè¶ ããŠããã®æ¬ã¯æ å ±ãã©ã®ããã«æµéã»çµ±å¶ãããããæ€èšŒããŠããã
ãšã©ã€ãžã£ã¯ãæ¿åºãæ¢åã¡ãã£ã¢ããã¯ãããžãŒãã©ãããã©ãŒã ããTrusted News InitiativeïŒTNIïŒã®ãããªåãçµã¿ãéããŠãããçš®ã足䞊ã¿ãããããŠããããšèª¬æããã
TNIã¯ããã®ãŠã§ããµã€ãã«ããã°ã2019幎ã«ãåœæ å ±ãšãã課é¡ã«åãçµããããã«ç«ã¡äžããããã
ãããã¯åœŒããâåœæ å ±âãšèŠãªããã®ã§ãããšãšã©ã€ãžã£ã¯èšããããããŠèªãããšãèš±ãããã®ã¯ã圌ãã®å ¬èªã®ç©èªã ããªã®ã§ããã
ãšã©ã€ãžã£ã¯TNIã®è²¬ä»»è ãšããŠã®BBCã®åœ¹å²ãæããã圌女ã¯ãBBCããã§ã€ã¹ããã¯ã®ãããªãœãŒã·ã£ã«ãã©ãããã©ãŒã äžã§ãŠãŒã¶ãŒè¡åãç£èŠããã¯ã¯ãã³ã«é¢ããåœæ å ±ãšèŠãªããã¢ã«ãŠã³ããé»ãããããšãèªããäºäŸãæåããã
ãããã飿ºã§ãããããããããã¯ãŒã¯ã§ãããšåœŒå¥³ã¯èšã£ããããããã®ã°ã«ãŒããæ€é²ããããã«ããã¹ãŠãäžäœãšãªã£ãŠåããŠããã®ã§ããã
ãã®åãçµã¿ã«ããããªã³ã©ã€ã³ã§èš±å®¹ãããèŠè§£ã®å¹ ã¯çãŸããèªç¶å ç«ãã¯ã¯ãã³ã®å¯åå¿ãšãã£ã話é¡ã«é¢ããã³ã³ãã³ããåé€ãããçµæãšãªã£ãã
圌女ã¯ãŸããã¡ãã£ã¢ãšç£æ¥çââãã¡ã€ã¶ãŒãšã®ã€ãªãããå«ãââã®çµã³ä»ãããæ©é¢æšªæçãªãåã蟌ã¿ïŒãã£ããã£ãŒïŒãã®èšŒæ ãšããŠææããã
ããã¡ã€ã¶ãŒã®åç· åœ¹ã§ãããžã§ãŒã ãºã»Cã»ã¹ãã¹ã¯ããã€ã¿ãŒã®åç· åœ¹ã§ããããŸãããšãšã©ã€ãžã£ã¯èšã£ããå€ãã®ãã¥ãŒã¹çªçµã®åºåã¯ããã¡ã€ã¶ãŒæäŸã§ãããšãªã£ãŠããããç¬ç«ããã¡ãã£ã¢ãªããŠååšããŸãããã
ææãžã®è§£æ¯å€ã¯ãç¥èãšçå®ã
æ¬æžãéããŠããšã©ã€ãžã£ã¯ææãäžè«ã®åå¿ã圢äœã£ããšäž»åŒµããã
圌女ã¯ããããããã¯ããŠã³ããã¯ã¯ãã³çŸ©ååãããžã¿ã«å¥åº·ãã¹ã«è³ããŸã§ã®æ¿çã«ã€ããŠã®ç²Ÿæ»ã劚ããé å®ãä¿ãããéµãšãªãææ®µãã ãšåŒãã ã
ã人ã ã®æ¹å€çæèåã奪ã£ãŠããŸããããŸãã«æããããã°ããªãã§ãããããã«ãªã£ãŠããŸãããšåœŒå¥³ã¯ãã£ã³ãã«ã«èªã£ãã圌女ã¯ãèªåã®ç®æšã¯ã人ã ãç®èŠããããããšâŠâŠæãããªãããã«ããããšãã ãšè¿°ã¹ãã
æ¬æžã«ã¯941ä»¶ã®åèæç®ãå«ãŸããŠãããããã¯æ¬æžã®äžæ žçãªåæãåæ ããŠãããšãšã©ã€ãžã£ã¯èªã£ãããããããã¹ãŠãžã®è§£æ¯å€ã¯ç¥èãšçå®ã§ãããããããã°ãæããå¿ èŠã¯ãããŸããããšåœŒå¥³ã¯èšã£ãã
圌女ã¯ããã®æ¬ãæšæž¬ã§ã¯ãªãã調æ»ãšèšŒæ ã«åºã¥ããŠããããšã匷調ãããã倿ããã®ã¯èªè 次第ã§ãããšåœŒå¥³ã¯èšã£ãããç§ã¯ãã èšé²ããŠããã ããèšè¿°ããŠããã ãããããŠãæ¬æ¥ãªãããã¹ãã ã£ã調æ»å ±éãããŠããã®ã§ããã
ãã£ã³ãã«ãäž»æµå ±éãžã®ãã®æ¹å€ã«å調ããããèªç±ãªå ±éã¯ãèªç±ã«æ©èœããæ°äž»ç€ŸäŒã«äžå¯æ¬ ã ããç§ãã¡ã«ã¯ããããªãããšåœŒã¯è¿°ã¹ãã
å°æ¥ãèŠæ®ãããšã©ã€ãžã£ã¯æ å ±çµ±å¶ã匷ãŸãå¯èœæ§ãèŠåããããã€ã³ã¿ãŒãããã®çµ±å¶ãé²ãã®ãç®ã«ããã§ãããâŠâŠãªããªãçå®ã¯åºããããã§ãããšåœŒå¥³ã¯èšã£ããããããŠåœŒãã¯çå®ãåºããã®ãæãã§ããŸãããã
ãšã©ã€ãžã£ãæ°åã«ã€ããŠèªãæ§åã¯ãã¡ããã芧ãã ããïŒ
